Epicore Biosystems, creators of the Gx Sweat Patch, acquired assets and IP from Eccrine Systems, makers of a patch measuring stress, pain, and more from human sweat.
United in Sweat
Despite raising $20M over its history, Eccrine ceased operations in 2020. Now, Epicore is reviving its IP, complementing its own sport-specific patch with Eccrine’s focus in precision medicine.
Why it matters: Fresh off a $10M Series A this February for its microfluidic (sweat-analyzing) patch that measures hydration, stress, and blood glucose, Epicore Biosystems will complement its real-time performance metrics with remote patient monitoring capabilities, including drug and alcohol program adherence.
The market for noninvasive biowearables is ballooning as prescription wearables and the quantified self movement blend.
- In November 2021, Biolinq secured $100M for its glucose-monitoring skin patch.
- FLOWBIO, creators of a biowearable patch that detects electrolyte and fluid loss in real time, is launching a closed beta in 2022.
- Researchers at OSU are developing a device worn on the ear or fingernail which can detect gases emitted from the skin, measuring blood glucose, fat-burning rate, and more.
Looking ahead: From smart rings to contact lenses to sweat patches, consumers are demanding wearables with more feedback and less friction.